Syndax Pharmaceuticals

Subscribe to the company

Syndax Pharmaceuticals

Connections 1

Description

Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company that is focused on developing a pipeline of cancer therapies. The Company’s lead product candidates include SNDX-5613 and SNDX-6352 (axatilimab).

The Company is focused on developing SNDX-5613, targeting the binding interaction of menin with the mixed lineage leukemia 1 (MLL1), protein for the treatment of MLL-rearranged (MLLr), acute leukemias and nucleophosmin 1 (NPM1), mutant acute myeloid leukemia (AML), as well as axatilimab, a monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor.

The Company’s products candidate also includes entinostat, once-weekly, oral, small molecule and Class I histone deacetylases (HDAC) inhibitor that being evaluated in the Phase III E2112 registrational clinical trial in combination with exemestane for hormone receptor positive, human epidermal growth factor receptor 2 negative and breast cancer.

Website

http://www.syndax.com

Rating GlobalNY.biz

Take place №2972 In rating New York Organizations general
Take place №284 In rating Healthcare area

<!-- advertisement 10-->
<div class="mobileShow">
<script>
  atOptions = {
    'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
    'format' : 'iframe',
    'height' : 250,
    'width' : 300,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script>
  atOptions = {
    'key' : '60966449084d21264769e3d9bdff986a',
    'format' : 'iframe',
    'height' : 90,
    'width' : 728,
    'params' : {}
  };
</script>
<script src="https://www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

24 May 2022

Business

The US stock market closed higher on Monday: The Dow Jones up 1.98%

Company stocks in trading on Monday US stock indices have been in the green zone since the start of...

<!-- advertisement 12-->
<div class="mobileShow">
<script type="text/javascript">
	atOptions = {
		'key' : '33fb986b72fdc254fb0c1e79be22e3ec',
		'format' : 'iframe',
		'height' : 250,
		'width' : 300,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/33fb986b72fdc254fb0c1e79be22e3ec/invoke.js"></script>
</div>
<div class="mobileHide">
<script type="text/javascript">
	atOptions = {
		'key' : '60966449084d21264769e3d9bdff986a',
		'format' : 'iframe',
		'height' : 90,
		'width' : 728,
		'params' : {}
	};
</script>
<script type="text/javascript" src="//www.highperformanceformat.com/60966449084d21264769e3d9bdff986a/invoke.js"></script>
</div>

Syndax Pharmaceuticals

Description

Website

Rating GlobalNY.biz

Mentions in the news View all

The US stock market closed higher on Monday: The Dow Jones up 1.98%

Quotes

Brenda Vaccaro Reveals Why She Left Michael Douglas

NASA Names Astronaut Christina Koch Acting Deputy Chief Engineer

Blondie Reopens Its New York Story With High Noon

Pedro Pascal Discovers His Most Intimidating Co-Star Is a Cello

Paul Bettany Reveals the Call That Rebuilt His Hollywood Career

Press Releases

Archaeogenetics: What Ancient DNA Reveals About the Origins of Lineages and Peoples

NASA Names Astronaut Christina Koch Acting Deputy Chief Engineer

News

Brenda Vaccaro Reveals Why She Left Michael Douglas

Blondie Reopens Its New York Story With High Noon

Birthdays

COSBY Mary

KIRKPATRICK Christopher

KEOGHAN Barry

MACFADYEN David

EAVIS Michael

Recent vacancies

Director | performance and quality improvement

Booker

Retail fulfillment associate

Editorial assistant - knopf/pantheon books

Associate ii warehouse ops - night

Resume

BURTON Julian Jay Burton None

FESTA Matthew n/a

NGUYEN Jaron N/A

Syndax Pharmaceuticals

Description

Website

Rating GlobalNY.biz

Mentions in the news View all

NEW YORK COMPANIES